1st Circ. Kills Investor Suit Over Boston Scientific Sales
A three-judge panel agreed with a Massachusetts federal judge's finding that the shareholders' securities fraud claims didn't meet the standards required by the Securities Litigation Uniform Standards Act.
The plaintiffs, who originally launched the suit in 2010, had alleged that Boston Scientific...
To view the full article, register now.